S&P 500   3,104.90 (+0.04%)
DOW   27,817.06 (+0.18%)
QQQ   201.17 (-0.26%)
CGC   18.38 (-9.41%)
BABA   184.63 (-0.12%)
GE   11.64 (+0.95%)
T   37.86 (+0.66%)
ACB   2.77 (-11.52%)
PRI   131.00 (+0.42%)
BAC   33.16 (+0.97%)
DIS   147.67 (+0.52%)
S&P 500   3,104.90 (+0.04%)
DOW   27,817.06 (+0.18%)
QQQ   201.17 (-0.26%)
CGC   18.38 (-9.41%)
BABA   184.63 (-0.12%)
GE   11.64 (+0.95%)
T   37.86 (+0.66%)
ACB   2.77 (-11.52%)
PRI   131.00 (+0.42%)
BAC   33.16 (+0.97%)
DIS   147.67 (+0.52%)
S&P 500   3,104.90 (+0.04%)
DOW   27,817.06 (+0.18%)
QQQ   201.17 (-0.26%)
CGC   18.38 (-9.41%)
BABA   184.63 (-0.12%)
GE   11.64 (+0.95%)
T   37.86 (+0.66%)
ACB   2.77 (-11.52%)
PRI   131.00 (+0.42%)
BAC   33.16 (+0.97%)
DIS   147.67 (+0.52%)
S&P 500   3,104.90 (+0.04%)
DOW   27,817.06 (+0.18%)
QQQ   201.17 (-0.26%)
CGC   18.38 (-9.41%)
BABA   184.63 (-0.12%)
GE   11.64 (+0.95%)
T   37.86 (+0.66%)
ACB   2.77 (-11.52%)
PRI   131.00 (+0.42%)
BAC   33.16 (+0.97%)
DIS   147.67 (+0.52%)
Log in

Procyon Stock Price, Forecast & Analysis (OTCMKTS:PCYN)

$0.19
-0.01 (-4.00 %)
(As of 11/22/2019 08:56 AM ET)
Today's Range
$0.19
Now: $0.19
$0.19
50-Day Range
$0.19
MA: $0.23
$0.28
52-Week Range
$0.19
Now: $0.19
$0.32
Volume1,300 shs
Average Volume6,433 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Procyon Corporation, together with its subsidiaries, develops and markets proprietary medical products for use in the treatment of pressure ulcers, stasis ulcers, wounds, dermatitis, inflammation, and other skin problems primarily in the United States. The company offers advanced skin and wound care products, including the hydrogel wound dressing products, post op surgical kits, saline wound washes, care lotions, and barrier lotions to promote healing in wound and problematic skin conditions under the AMERIGEL brand name. It also provides Bioactive Collagen products under the HELIX3 brand name. In addition, the company offers wound care products, such as calcium alginate, foam, gauze, and hyrdocolloid dressing products; wound care kits, which include calcium alginate, collagen matrix, collagen powder, foam, and hydrogel wound care kits under the AMERX brand name; and compression garment line products under the EXTREMIT-EASE name. It sells its products through distributors to institutional customers, such as hospitals, wound care clinics, skilled nursing facilities, home health agencies, physicians, and other health care practitioners; and retail customers through direct sales, and Internet sales, as well as through independent and retail chain drug stores. Procyon Corporation was incorporated in 1987 and is based in Clearwater, Florida.

Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:PCYN
CUSIP742806300
Phone727-447-2998

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees16
Next Earnings DateN/A
OptionableNot Optionable

Receive PCYN News and Ratings via Email

Sign-up to receive the latest news and ratings for PCYN and its competitors with MarketBeat's FREE daily newsletter.


Procyon (OTCMKTS:PCYN) Frequently Asked Questions

What is Procyon's stock symbol?

Procyon trades on the OTCMKTS under the ticker symbol "PCYN."

Has Procyon been receiving favorable news coverage?

Media coverage about PCYN stock has been trending somewhat positive recently, InfoTrie reports. The research group identifies negative and positive media coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Procyon earned a coverage optimism score of 1.5 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the next few days. View News Stories for Procyon.

Who are some of Procyon's key competitors?

What other stocks do shareholders of Procyon own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Procyon investors own include Aphria (APHA), California Republic Bancorp (CRPB) and Aerie Pharmaceuticals (AERI).

Who are Procyon's key executives?

Procyon's management team includes the folowing people:
  • Mr. Justice W. Anderson, CEO, Pres & Director (Age 42)
  • Mr. James B. Anderson, CFO & Director (Age 49)
  • Mr. George Otis Borak, VP of Sales - Amerx Health Care Corp. (Age 58)

How do I buy shares of Procyon?

Shares of PCYN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Procyon's stock price today?

One share of PCYN stock can currently be purchased for approximately $0.19.

What is Procyon's official website?

The official website for Procyon is http://procyoncorp.com/.

How can I contact Procyon?

The company can be reached via phone at 727-447-2998.


MarketBeat Community Rating for Procyon (OTCMKTS PCYN)

Community Ranking:  1.9 out of 5 (star)
Outperform Votes:  18 (Vote Outperform)
Underperform Votes:  30 (Vote Underperform)
Total Votes:  48
MarketBeat's community ratings are surveys of what our community members think about Procyon and other stocks. Vote "Outperform" if you believe PCYN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PCYN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/22/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel